Publicaciones (134) Publicaciones de MIGUEL ALCOCEBA SANCHEZ

filter_list Internal%20Medicine

2026

  1. Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53)

    British Journal of Haematology

  2. Immunotherapy may be preferable to chemotherapy for patients with POD24 follicular lymphoma in the second-line setting

    British Journal of Haematology

  3. Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis

    Leukemia

  4. Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis

    Modern Pathology, Vol. 39, Núm. 7

  5. Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters—A study from the Spanish Lymphoma Group GELTAMO

    British Journal of Haematology

2025

  1. Altered immune cell profiles in blood of mature/peripheral T-cell leukemia/lymphoma patients: an EuroFlow study

    Frontiers in Immunology, Vol. 16

  2. Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenström Macroglobulinemia

    American Journal of Hematology

  3. Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia

    Haematologica, Vol. 110, Núm. 8, pp. 1758-1773

  4. Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL

    HemaSphere, Vol. 9, Núm. 1

  5. Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

    Leukemia, Vol. 39, Núm. 9, pp. 2076-2086

  6. Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

    Molecular Oncology, Vol. 19, Núm. 11, pp. 3175-3192

  7. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)

    Medicina Clinica, Vol. 164, Núm. 6, pp. 305-305.e17

  8. Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

    Blood Advances, Vol. 9, Núm. 23, pp. 6076-6089

  9. Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemia

    Blood, Vol. 146, Núm. 26, pp. 3213-3227

  10. Maturation-Related and Functional-Associated Phenotypic Profile of Tumor T Cells in Mature/Peripheral T-Cell Neoplasms: Association With the Diagnostic Subtype of the Disease

    Laboratory Investigation, Vol. 105, Núm. 8

  11. NK Alloreactivity Evaluation According to KIR-HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem-Cell Transplantation Based on Post-Transplant Cyclophosphamide

    HLA, Vol. 106, Núm. 2

  12. Prevalence and characterisation of circulating T-cell clones of uncertain significance in healthy subjects by highly sensitive flow cytometry

    XI Jornadas de Investigadoras de Castilla y León: la aventura de la ciencia y tecnología (Servicio de Publicaciones e Imagen Institucional), pp. 78

  13. State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

    Blood Cancer Journal, Vol. 15, Núm. 1

  14. The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential

    Blood Advances, Vol. 9, Núm. 12, pp. 2953-2967

  15. Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

    Molecular Oncology, Vol. 19, Núm. 12, pp. 3706-3728